Drug intelligence / Profile preview

Zinbro-S

Development stage
Unknown
Lead developer
Sapient Laboratories
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Zinbro-S is an approved ophthalmic combination solution developed and marketed by Sapient Laboratories for the treatment of bacterial eye infections and associated symptoms such as irritation, redness, and itching. The formulation contains sulfacetamide (a sulfonamide antibiotic that inhibits bacterial dihydropteroate synthase to block folic acid synthesis), chlorpheniramine maleate (an antihistamine that targets the histamine H1 receptor to alleviate allergic symptoms), zinc sulfate (an astringent that reduces redness and irritation), boric acid (a mild antiseptic), sodium chloride (to maintain isotonicity), and chlorobutanol (as a preservative). It is indicated for conditions such as conjunctivitis, blepharitis, iritis, trachoma, and ophthalmia neonatorum.

Brand names
Zinbro-S
Other names
Zinbro-S Eye DropsZinbro-S Ophthalmic Solution
02

Targets

DHPS (Dihydropteroate synthase)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Zinbro-S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinbro-S.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call